Clinical trial
Cilengitide (EMD121974) in Combination With Irradiation in Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Glioma: Phase I Study
NCT01165333 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cilengitide (EMD121974) in Combination With Irradiation in Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Glioma: Phase I Study
- Lead sponsor
- Centre Oscar Lambret
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 6, 2010
- Completion date
- March 31, 2015
- Enrollment
- 32 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.